Table 1 Patient demographics, age,... | American Society of Hematology

Table 1

Patient demographics, age, genetic mutation, immune status, and influenza vaccination

Patient	Age, y	Mutation	TLC	% CD3	% CD4	% CD8	% CD19	TCF	Year of flu vaccination
XLA 1	23	R28C	2.0	93	56	32	< 1	NA	2002
XLA 2	27	E636X	2.2	95	64	28	< 1	Normal	2005
XLA 3	24	E636X	2.2	95	67	26	< 1	Normal	2005
XLA 4	23	E636X	2.1	95	69	22	< 1	Normal	2005
XLA 5	36	R28C	0.8	95	32	53	< 1	Normal	2005
XLA 6	24	R28C	1.5	92	50	26	< 1	NA	NA
XLA 8	38	R28C	2.0	70	55	19	2	NA	2005
X-HIM 1	37	560delA	0.9	74	48	23	2	NA	NA
X-HIM 2	55	148T>C, 617T>A, and 618C>T	1.6	75	47	23	11	Normal	2006

Patient	Age, y	Mutation	TLC	% CD3	% CD4	% CD8	% CD19	TCF	Year of flu vaccination
XLA 1	23	R28C	2.0	93	56	32	< 1	NA	2002
XLA 2	27	E636X	2.2	95	64	28	< 1	Normal	2005
XLA 3	24	E636X	2.2	95	67	26	< 1	Normal	2005
XLA 4	23	E636X	2.1	95	69	22	< 1	Normal	2005
XLA 5	36	R28C	0.8	95	32	53	< 1	Normal	2005
XLA 6	24	R28C	1.5	92	50	26	< 1	NA	NA
XLA 8	38	R28C	2.0	70	55	19	2	NA	2005
X-HIM 1	37	560delA	0.9	74	48	23	2	NA	NA
X-HIM 2	55	148T>C, 617T>A, and 618C>T	1.6	75	47	23	11	Normal	2006

TCF indicates T-cell function in response to phytohemagglutinin; TLC, total lymphocyte count; and NA, not available.